Merck and Elsevier Published Fake Journal |
| Print | |
|
Monday May 04, 2009
|
|||||||
|
Multiple sources are pointing to a new report that Merck paid Elsevier, a leading publisher, to produce several volumes of the Australasian Journal of Bone and Joint Medicine, which appeared to be a peer-reviewed journal, but was really little more than marketing material for the pharmaceutical company.
Comments (3)
![]()
Anon Name
said:
|
|||||||
|
And educational institutions subscribe to Elsevier ScienceDirect 1. Publish a fake journal with Elsevier and the like 2. Make educational institurions subscribe to Elsevier and the like 3. Tie university professors with Big Pharma 4. PROFIT! Regarding [3], visit http://www.ahrp.org/cms/content/view/523/9/ Harvard Medical Students Rebel Against Big Pharma "The students say they worry that pharmaceutical industry scandals in recent years - including some criminal convictions, billions of dollars in fines, proof of bias in research and publishing and false marketing claims - have cast a bad light on the medical profession. And they criticize Harvard as being less vigilant than other leading medical schools in monitoring potential financial conflicts by faculty members." |
|
Marketing material, yes, but... The info that the publication was paid for by Merck could be inferred, if you took the time. In the item pointed to, the ONLY advertisements were from Merck (at least that was the only ones that I noticed). However, I'd agree that it should have been specifically mentioned. Sort of like the "Medi-Facts" commercials airing these days. |
|
answer I took my first loans when I was 20 and this aided me very much. However, I require the commercial loan once again. |
We want to enhance competition and investment in this country, and this is why we adopted this policy back in 2008 for the AWS spectrum. Let me say that the price went down by an average of 11% since then, and we will continue this way with the 700 megahertz spectrum. We launched consultation with the industry to make sure that we enhance competition and provide better choice and better rates for our consumers.